Top Markets
#1 Islamic Coin Islamic Coin +155.93%
#2 Siren Siren +36.39%
#3 OpenEden OpenEden +22.90%
#4 Arowana Arowana +21.66%
#5 Nockchain Nockchain +17.94%
#6 Venom Venom +17.03%
#7 RedStone RedStone +13.02%
#8 KUB Coin KUB Coin +12.52%
#9 Perle Perle +12.08%
#10 Cysic Cysic +11.29%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Polyrizon Ltd. Polyrizon Ltd.

Polyrizon Ltd.

PLRZ
Rangering i aksjer #31773
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of... Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
Aksjekurs
$10.81
Sist synkronisert: 2026-08-17
Markedsverdi
$12.11M
Endring (1 dag)
-1.55%
Endring (1 år)
74.92%
Land
IL
Handel Polyrizon Ltd. (PLRZ)

Kategori

Healthcare
P/S-forhold for Polyrizon Ltd. (PLRZ)
P/S-forhold per 2026 TTM: 0
Ifølge Polyrizon Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Polyrizon Ltd. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR